Future study should evaluate more specific endothelial cell inflammatory markers (i.e., soluble p-selectin) in cirrhosis with HCC and assess whether such markers could have prognostic or therapeutic potential in these patients. The gene discussed is SELP; the disease is Cirrhosis.